share_log

ITeos Therapeutics Expects Topline Data From Phase 1 Trial In 2H 2024

Benzinga ·  May 10 20:29
ITeos Therapeutics Expects Topline Data From Phase 1 Trial In 2H 2024
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment